RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

Item

http://www.wikidata.org/entity/Q33476226

Q33476226

about

Recognition of damage-associated molecular patterns related to nucleic acids during inflammation and vaccination Immune signaling by RIG-I-like receptors Biomarkers and Autoantibodies of Interstitial Lung Disease with Idiopathic Inflammatory Myopathies Clinical Usefulness of Autoantibodies in Idiopathic Inflammatory Myositis The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum MDA5 autoantibody-another indicator of clinical diversity in dermatomyositis.Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.Deciphering the clinical presentations, pathogenesis, and treatment of the idiopathic inflammatory myopathies.Prognostic factors for myositis-associated interstitial lung disease Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.Autoantibodies against a 43 KDa muscle protein in inclusion body myositis Dermatomyositis and type 1 interferons.RNA helicases in infection and disease.Cutaneous dermatomyositis: an updated review of treatment options and internal associations.Type 1 interferons and myositis.Anti-MDA5 autoantibodies in juvenile dermatomyositis identify a distinct clinical phenotype: a prospective cohort study.Treatment of Clinically Amyopathic Dermatomyositis in adults: A Systematic Review.Calcinosis in juvenile dermatomyositis is influenced by both anti-NXP2 autoantibody status and age at disease onset.Meta-analysis of the association of dermatomyositis and polymyositis with cancer.Common and distinct clinical features in adult patients with anti-aminoacyl-tRNA synthetase antibodies: heterogeneity within the syndrome.Autoantibodies to survival of motor neuron complex in patients with polymyositis: immunoprecipitation of D, E, F, and G proteins without other components of small nuclear ribonucleoproteins.Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.Prognostic significance of anti-aminoacyl-tRNA synthetase antibodies in polymyositis/dermatomyositis-associated interstitial lung disease: a retrospective case control study The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study Myositis-specific autoantibodies: detection and clinical associations.The lung as a possible target for the immune reaction in myositis.Inflammatory myopathy with anti-signal recognition particle antibodies: case series of 100 patients.Autoantibodies to transcription intermediary factor 1 in dermatomyositis shed insight into the cancer-myositis connection Clinical Characteristics of Anti-3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Antibodies in Chinese Patients with Idiopathic Inflammatory Myopathies Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?Epidemiologic study of clinically amyopathic dermatomyositis and anti-melanoma differentiation-associated gene 5 antibodies in central Japan.Autoantibody Profiles in Collagen Disease Patients with Interstitial Lung Disease (ILD): Antibodies to Major Histocompatibility Complex Class I-Related Chain A (MICA) as Markers of ILD.Clinical Utility of an Enzyme-Linked Immunosorbent Assay for Detecting Anti-Melanoma Differentiation-Associated Gene 5 Autoantibodies.Oropharyngeal Dysphagia in Dermatomyositis: Associations with Clinical and Laboratory Features Including Autoantibodies.Factors Associated with Interstitial Lung Disease in Patients with Polymyositis and Dermatomyositis: A Systematic Review and Meta-Analysis Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis.Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study.Polymyositis and dermatomyositis as a risk of developing cancer.Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis

P2860

Q21131298-30A055C5-DF7F-4B20-ACE5-F9F94D0934C1 Q24304438-BF822C1F-8479-44DE-9800-6EB2AA7FECC4 Q26824432-CBF4A0FA-3FDE-4D8A-A2FC-6DA54261EF78 Q26862492-86C0312C-3BAB-4D9D-9BFD-3CA291504E4B Q27014908-5DC86C6F-552C-42F5-AA8B-754714D296ED Q33592767-658E567D-6F4F-4303-9F20-22EC5C1019F6 Q33688739-658E575F-3C2B-487A-A74E-561AE6A6BBC4 Q33704562-3EF80B83-4E14-4A25-8224-6BFAB3C549DC Q33717793-ED3DED94-C588-4C5F-9512-9F05B0EDBDBC Q33721518-514FA44C-07F9-4CF3-B56C-31EC513BFCF1 Q33814323-6C8DA9CC-FA38-4662-BE9B-34C80A7A5009 Q33918389-A70F1C9D-1DF7-46DC-90E4-4D24446B38FD Q34090905-F557542E-2570-4434-A4CA-34D4D598BC1E Q34281605-904F3A27-55FC-479C-913B-693754B4B796 Q34349952-5A8DF5A6-E215-4348-93DF-E45D923D499A Q34350190-5B712B45-DF3C-44E7-8B8B-2CF09D10AFEE Q34486301-161509EA-9712-43DE-9954-E87B7AB86BC3 Q34526090-0FF5A268-2A89-401B-A8A1-E12A9045D511 Q34563223-915F79E3-8BC8-4B27-9A98-93396B9BD580 Q34654935-A9D31F3D-B058-430A-A5DB-D2EBEF074B89 Q34661961-5613E9DC-A44C-42EE-8027-C274F02415BD Q35069634-C922895A-9595-46A0-A66C-25555C377BAE Q35092898-B408FB46-DF69-4E1A-B0F7-DC2D89E62E69 Q35195954-D4CCF933-44DE-4ECB-BC70-1FD3B132CEB2 Q35198594-169C6156-F4A8-4A68-ACF5-059C33B56756 Q35309808-EF28F5DD-FCD8-46AC-BDC8-3B9342F70D91 Q35617570-9C47D2B0-AC02-404E-8386-C1983F36DBEA Q35632755-407D4060-F8FB-49C6-8987-4A30F6911DFE Q35706669-65A12423-F5FC-47A6-86CC-2CBA2FE375C8 Q35824298-95960A3D-8A01-4D3A-91B2-FA6FD81571C8 Q35864644-66B48337-AFF4-4740-BCA1-D83A6D63F5FC Q35907850-D6C9A16B-F0B4-44A0-8706-481953A58B7A Q35962818-60CDEA8E-FE13-432E-93A0-08884ACBBED0 Q35999311-264AA620-FE84-49C4-B243-F987130DC543 Q36014488-C1B24B8C-22C7-42DC-957F-53A1F55BED2C Q36015534-B65FEA67-A8CC-43F2-BA9E-7AC2B5CE9DD6 Q36245820-23F28E0F-9078-4E0E-82E5-E1086E46FB8D Q36656406-BEADA3CE-3E30-43A0-A3C6-BB1AD9CFF7EE Q36842357-1CB1A653-0168-4EEF-9F6B-D84CFBE07950 Q36893955-3F1D96E6-6530-4160-8435-3FEEB72FEF10

P2860

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

Item

http://www.wikidata.org/entity/Q33476226

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu